Jingnan Shen

Targeting NAT10 inhibits osteosarcoma progression via ATF4/ASNS-mediated asparagine biosynthesis

Efficacy and safety of JMT103 in patients with unresectable or surgically-challenging giant cell tumor of bone: a multicenter, phase Ib/II study

Landscape of somatic alterations in large-scale solid tumors from an Asian population

METTL14-mediated epitranscriptome modification of MN1 mRNA promote tumorigenicity and all-trans-retinoic acid resistance in osteosarcoma

Hereditary retinoblastoma iPSC model reveals aberrant spliceosome function driving bone malignancies

AHA1 upregulates IDH1 and metabolic activity to promote growth and metastasis and predicts prognosis in osteosarcoma

Targeting Super-Enhancer–Associated Oncogenes in Osteosarcoma with THZ2, a Covalent CDK7 Inhibitor

Chromosomal translocation-derived aberrant Rab22a drives metastasis of osteosarcoma

CDH4 is a novel determinant of osteosarcoma tumorigenesis and metastasis

lncRNA DANCR promotes tumor progression and cancer stemness features in osteosarcoma by upregulating AXL via miR-33a-5p inhibition

Microarray Expression Profile and Functional Analysis of Circular RNAs in Osteosarcoma

Degalactotigonin, a Natural Compound from <i>Solanum nigrum L</i> ., Inhibits Growth and Metastasis of Osteosarcoma through GSK3β Inactivation–Mediated Repression of the Hedgehog/Gli1 Pathway

MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1

IRX1 hypomethylation promotes osteosarcoma metastasis via induction of CXCL14/NF-κB signaling

Downregulation of MCT1 inhibits tumor growth, metastasis and enhances chemotherapeutic efficacy in osteosarcoma through regulation of the NF-κB pathway